相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Programmed Cell Death Ligand-1 (PD-L1) and CD8 Expression Profiling Identify an Immunologic Subtype of Pancreatic Ductal Adenocarcinomas with Favorable Survival
Ludmila Danilova et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Broadening the Impact of Immunotherapy to Pancreatic Cancer: Challenges and Opportunities
Vinod P. Balachandran et al.
GASTROENTEROLOGY (2019)
Experimental microdissection enables functional harmonisation of pancreatic cancer subtypes
Carlo Maurer et al.
GUT (2019)
Tumour buds determine prognosis in resected pancreatic ductal adenocarcinoma
Philipp Lohneis et al.
BRITISH JOURNAL OF CANCER (2018)
The Immune Revolution: A Case for Priming, Not Checkpoint
Robert H. Vonderheide
CANCER CELL (2018)
Evaluating Mismatch Repair Deficiency in Pancreatic Adenocarcinoma: Challenges and Recommendations
Zishuo I. Hu et al.
CLINICAL CANCER RESEARCH (2018)
Integrated Genomic and Immunophenotypic Classification of Pancreatic Cancer Reveals Three Distinct Subtypes with Prognostic/Predictive Significance
Martin Wartenberg et al.
CLINICAL CANCER RESEARCH (2018)
A Pan-cancer Landscape of Interactions between Solid Tumors and Infiltrating Immune Cell Populations
David Tamborero et al.
CLINICAL CANCER RESEARCH (2018)
Prevalence of Microsatellite Instability in Intraductal Papillary Mucinous Neoplasms of the Pancreas
Renato M. Lupinacci et al.
GASTROENTEROLOGY (2018)
Tumour budding in pancreatic cancer revisited: validation of the ITBCC scoring system
Eva Karamitopoulou et al.
HISTOPATHOLOGY (2018)
Involvement of partial EMT in cancer progression
Masao Saitoh
JOURNAL OF BIOCHEMISTRY (2018)
Update on Tumor Neoantigens and Their Utility: Why It Is Good to Be Different
Chung-Han Lee et al.
TRENDS IN IMMUNOLOGY (2018)
Multi-omics analysis reveals neoantigen-independent immune cell infiltration in copy-number driven cancers
Daniel J. McGrail et al.
NATURE COMMUNICATIONS (2018)
Immunotherapy for Pancreatic Cancer: More Than Just a Gut Feeling
Erick Riquelme et al.
CANCER DISCOVERY (2018)
Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer
Herve Tiriac et al.
CANCER DISCOVERY (2018)
Prevalence of PDL1 Amplification and Preliminary Response to Immune Checkpoint Blockade in Solid Tumors
Aaron M. Goodman et al.
JAMA ONCOLOGY (2018)
Association of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinoma
Zhi Rong Qian et al.
JAMA ONCOLOGY (2018)
Targeting the TGFβ pathway with galunisertib, a TGFβRI small molecule inhibitor, promotes anti-tumor immunity leading to durable, complete responses, as monotherapy and in combination with checkpoint blockade
Rikke B. Holmgaard et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Immune Evasion in Pancreatic Cancer: From Mechanisms to Therapy
Neus Martinez-Bosch et al.
CANCERS (2018)
Immune Cell and Stromal Signature Associated With Progression-Free Survival of Patients With Resected Pancreatic Ductal Adenocarcinoma
Ujjwal Mukund Mahajan et al.
GASTROENTEROLOGY (2018)
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
T. Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Expression profiling of budding cells in colorectal cancer reveals an EMT-like phenotype and molecular subtype switching
Linde De Smedt et al.
BRITISH JOURNAL OF CANCER (2017)
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
John P. Neoptolemos et al.
LANCET (2017)
MicroRNA dysregulation in the tumor microenvironment influences the phenotype of pancreatic cancer
Eva Karamitopoulou et al.
MODERN PATHOLOGY (2017)
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
Vinod P. Balachandran et al.
NATURE (2017)
MicroRNA-200b is downregulated in colon cancer budding cells
Kirsten Nguyen Knudsen et al.
PLOS ONE (2017)
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Dung T. Le et al.
SCIENCE (2017)
Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer
Julienne L. Carstens et al.
NATURE COMMUNICATIONS (2017)
Association of Distinct Mutational Signatures With Correlates of Increased Immune Activity in Pancreatic Ductal Adenocarcinoma
Ashton A. Connor et al.
JAMA ONCOLOGY (2017)
Targeting the hepatocyte growth factor/Met pathway in cancer
Dinuka M. De Silva et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2017)
Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma
Andrew J. Aguirre et al.
CANCER CELL (2017)
Stratification of Pancreatic Ductal Adenocarcinoma: Combinatorial Genetic, Stromal, and Immunologic Markers
Erik S. Knudsen et al.
CLINICAL CANCER RESEARCH (2017)
Spatial distribution of B cells predicts prognosis in human pancreatic adenocarcinoma
Giovanni Francesco Castino et al.
ONCOIMMUNOLOGY (2016)
Genomic analyses identify molecular subtypes of pancreatic cancer
Peter Bailey et al.
NATURE (2016)
Genomic instability in pancreatic adenocarcinoma: a new step towards precision medicine and novel therapeutic approaches
Ibrahim H. Sahin et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2016)
Tumor Budding: The Name is EMT. Partial EMT.
Alexandru Dan Grigore et al.
JOURNAL OF CLINICAL MEDICINE (2016)
Tumor Budding Is an Independent Adverse Prognostic Factor in Pancreatic Ductal Adenocarcinoma
Kate O'Connor et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2015)
Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotype and suggests heterogeneity of stromal cells in pancreatic cancer
J. A. Galvan et al.
BRITISH JOURNAL OF CANCER (2015)
Detailed analysis of epithelial-mesenchymal transition and tumor budding identifies predictors of long-term survival in pancreatic ductal adenocarcinoma
Ilona Kohler et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2015)
Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma
Richard A. Moffitt et al.
NATURE GENETICS (2015)
Accumulation of FOXP3+T-cells in the tumor microenvironment is associated with an epithelial-mesenchymal-transition-type tumor budding phenotype and is an independent prognostic factor in surgically resected pancreatic ductal adenocarcinoma
Martin Wartenberg et al.
ONCOTARGET (2015)
Immune Escape Mechanisms as a Guide for Cancer Immunotherapy
Gregory L. Beatty et al.
CLINICAL CANCER RESEARCH (2015)
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
Lola Rahib et al.
CANCER RESEARCH (2014)
Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression
Limo Chen et al.
NATURE COMMUNICATIONS (2014)
Tumour budding is a strong and independent prognostic factor in pancreatic cancer
E. Karamitopoulou et al.
EUROPEAN JOURNAL OF CANCER (2013)
Activated Pancreatic Stellate Cells Sequester CD8+ T Cells to Reduce Their Infiltration of the Juxtatumoral Compartment of Pancreatic Ductal Adenocarcinoma
Abasi Ene-Obong et al.
GASTROENTEROLOGY (2013)
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
Jonathan M. Ostrem et al.
NATURE (2013)
Molecular mechanisms of T cell co-stimulation and co-inhibition
Lieping Chen et al.
NATURE REVIEWS IMMUNOLOGY (2013)
T-Regulatory Cells: Key Players in Tumor Immune Escape and Angiogenesis
Andrea Facciabene et al.
CANCER RESEARCH (2012)
Combining immunotherapy and targeted therapies in cancer treatment
Matthew Vanneman et al.
NATURE REVIEWS CANCER (2012)
Network of WNT and Other Regulatory Signaling Cascades in Pluripotent Stem Cells and Cancer Stem Cells
Masaru Katoh
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2011)
Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy
Eric A. Collisson et al.
NATURE MEDICINE (2011)
Cancer cells in epithelial-to-mesenchymal transition and tumor-propagating-cancer stem cells: distinct, overlapping or same populations
S. Floor et al.
ONCOGENE (2011)
EMT: When epithelial cells decide to become mesenchymal-like cells
Raghu Kalluri
JOURNAL OF CLINICAL INVESTIGATION (2009)
分享论文
